bluebird bio, Inc. (BLUE): Price and Financial Metrics


bluebird bio, Inc. (BLUE)

Today's Latest Price: $76.25 USD

3.29 (4.51%)

Updated Nov 12 8:00pm

Add BLUE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

BLUE Stock Summary

  • bluebird bio Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 9.12% of US listed stocks.
  • With a price/sales ratio of 84.99, bluebird bio Inc has a higher such ratio than 97.97% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.23 for bluebird bio Inc; that's greater than it is for only 12.83% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to bluebird bio Inc are CUE, TBPH, DRNA, RARE, and OTIC.
  • BLUE's SEC filings can be seen here. And to visit bluebird bio Inc's official web site, go to www.bluebirdbio.com.
BLUE Daily Price Range
BLUE 52-Week Price Range

BLUE Stock Price Chart More Charts


BLUE Price/Volume Stats

Current price $76.25
Prev. close $72.96
Day low $73.00
Day high $76.47
50-day MA $91.54
200-day MA $123.24
52-week high $163.43
52-week low $72.02
Volume 1,442,600
Avg. volume 603,609
Dividend yield N/A
Market Cap 4.22B

bluebird bio, Inc. (BLUE) Company Bio


Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.





BLUE Latest News Stream


Event/Time News Detail
Loading, please wait...

BLUE Latest Social Stream


Loading social stream, please wait...

View Full BLUE Social Stream

BLUE Price Returns

1-mo -13.49%
3-mo -34.11%
6-mo -41.70%
1-year -36.25%
3-year 34.12%
5-year 84.94%
YTD -23.14%
2018 -44.30%
2017 188.65%
2016 -3.92%
2015 -29.98%
2014 337.18%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6732 seconds.